53 phenotypes from 8 alleles in 16 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Sykm1Btlr/Sykm1Btlr involves: C57BL/6J	decreased B cell number	J:199281
	increased neutrophil cell number	J:199281
	increased tumor necrosis factor secretion	J:199281
SykM2Btlr/Syk+ C57BL/6J-SykM2Btlr	abnormal NK cell differentiation	J:231803
	decreased inflammatory response	J:231803
SykM2Btlr/SykM2Btlr C57BL/6J-SykM2Btlr	abnormal NK cell differentiation	J:231803
	decreased inflammatory response	J:231803
Syktm1.1Nns/Syktm1.1Nns Commd10Tg(Vav1-icre)A2Kio/Commd10+ involves: C57BL/10 * CBA/Ca	abnormal blood vessel morphology	J:181715
	abnormal lymphatic vessel morphology	J:181715
	edema	J:181715
	normal mortality/aging	J:181715
Syktm1.1Nns/Syktm1.1Nns Lyz2tm1(cre)Ifo/Lyz2+ involves: 129P2/OlaHsd	normal homeostasis/metabolism phenotype	J:181715
	normal immune system phenotype	J:181715
	normal mortality/aging	J:181715
Syktm1.1Nns/Syktm1.1Nns Tg(CD2-icre)4Kio/0 involves: C57BL/10 * CBA/Ca	normal homeostasis/metabolism phenotype	J:181715
	normal immune system phenotype	J:181715
	normal mortality/aging	J:181715
Syktm1.1Nns/Syktm1.1Nns Tg(Pf4-icre)Q3Rsko/0 involves: C57BL/6	abnormal blood vessel morphology	J:181715
	abnormal lymphatic vessel endothelial cell morphology	J:181715
	abnormal lymphatic vessel morphology	J:181715
	abnormal platelet physiology	J:181715
	ascites	J:181715
	edema	J:181715
	intracranial hemorrhage	J:181715
	normal respiratory system phenotype	J:181715
Syktm1.1Nns/Syktm1.1Nns Tg(Tie1-cre)9Ref/0 Commd10Tg(Vav1-icre)A2Kio/Commd10+ involves: 129S1/Sv * 129X1/SvJ * C57BL/10 * CBA/Ca	abnormal lymphatic vessel morphology	J:181715
	normal mortality/aging	J:181715
Syktm1.1Tara/Syktm1.1Tara involves: 129P2/OlaHsd * C57BL/6	arrested B cell differentiation	J:115080
	increased B cell proliferation	J:114816
	perinatal lethality, incomplete penetrance	J:115080
Syktm1.2Tara/Syktm1.2Tara Tg(Cr2-cre)3Cgn/0 involves: 129P2/OlaHsd	abnormal B cell morphology	J:208904
Syktm1.2Tara/Syktm1.2Tara Tg(Itgax-cre)1-1Reiz/0 involves: 129P2/OlaHsd * C57BL/6 * CBA	normal homeostasis/metabolism phenotype	J:181715
	normal immune system phenotype	J:181715
	normal mortality/aging	J:181715
Syktm1b(EUCOMM)Hmgu/Syk+ C57BL/6N-Syktm1b(EUCOMM)Hmgu/Ieg	decreased exploration in new environment	J:211773
	decreased grip strength	J:211773
	decreased lean body mass	J:211773
	increased total body fat amount	J:211773
Syktm1b(EUCOMM)Hmgu/Syktm1b(EUCOMM)Hmgu C57BL/6N-Syktm1b(EUCOMM)Hmgu/Ieg	preweaning lethality, complete penetrance	J:211773
Syktm1Paw/Syktm1Paw involves: 129S1/Sv * 129X1/SvJ	abnormal B cell differentiation	J:29797
	abnormal blood vessel morphology	J:159112
	abnormal foot pad morphology	J:29797
	abnormal lymphangiogenesis	J:159112
	abnormal lymphatic vessel endothelium morphology	J:159112
	abnormal lymphatic vessel morphology	J:159112
	absent pre-B cells	J:29797
	decreased late pro-B cell number	J:29797
	dilated vasculature	J:159112
	enlarged lymphatic vessel	J:159112
	hemorrhage	J:29797
	hydrops fetalis	J:29797
	intracerebral hemorrhage	J:159112
	lymphatic vessel hyperplasia	J:159112
	postnatal lethality, complete penetrance	J:29797
Syktm1Tyb/Syktm1.2Tara Lyz2tm1(cre)Ifo/Lyz2+ involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6	abnormal neutrophil physiology	J:155479
	impaired granulocyte bactericidal activity	J:155479
Syktm1Tyb/Syktm1.2Tara Tg(S100A8-cre,-EGFP)1Ilw/0 involves: 129P2/OlaHsd * 129S2/SvPas * C3H * C57BL/6	impaired granulocyte bactericidal activity	J:155479
Syktm1Tyb/Syktm1Tyb involves: 129S2/SvPas	abnormal dendritic cell antigen presentation	J:147472
	abnormal neutrophil physiology	J:155479
	decreased tumor necrosis factor secretion	J:155479
	impaired granulocyte bactericidal activity	J:155479
	impaired neutrophil phagocytosis	J:155479
Syktm1Tyb/Syktm1Tyb involves: 129S2/SvPas * C57BL/6	abnormal osteoclast differentiation	J:89583
	decreased bone resorption	J:89583
Syktm1Tyb/Syktm1Tyb involves: 129S2/SvPas * C57BL/6 * DBA/2	abnormal T cell number	J:29796
	arrested B cell differentiation	J:29796
	chylous ascites	J:29796
	hemorrhage	J:29796
	neonatal lethality, incomplete penetrance	J:29796
	postnatal lethality, complete penetrance	J:29796
Syktm1Tyb/Syktm1Tyb involves: 129S2/SvPas * C57BL/6J	abnormal brain vasculature morphology	J:181715
	abnormal lung morphology	J:181715
	abnormal lymphatic vessel morphology	J:181715
	decreased lymphatic vessel endothelial cell number	J:181715
	intracranial hemorrhage	J:181715
	primary atelectasis	J:181715
	spinal hemorrhage	J:181715